The multispecific antibody field has long lacked a unified naming infrastructure. BioGlyph solves this by embedding building block provenance, chain identity, and format topology directly into the design workflow, capturing structural identity automatically from the moment a molecule is conceived.

Designing multispecific antibodies still means juggling Excel spreadsheets, lab notebooks, and folders full of PowerPoint diagrams - a fragmented workflow that breaks down fast as format complexity grows. There's a better way.